Multiple Rising Oral Doses of BI 1060469 in Healthy Subjects and Mild Asthma Patients

NCT02126865 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo to BI 1060469
DRUG: BI 1060469 Healthy
DRUG: Placebo to BI 1060469 asthmatics
DRUG: BI 1060469 asthmatics

Sponsor

Boehringer Ingelheim